Literature DB >> 34871857

Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis.

Antonio Luca Spiezia1, Vincenza Cerbone2, Eduardo Alberto Molinari3, Nicola Capasso1, Roberta Lanzillo1, Antonio Carotenuto1, Maria Petracca1, Federica Novarella1, Bianca Covelli3, Giulia Scalia2, Vincenzo Brescia Morra1, Marcello Moccia4.   

Abstract

Entities:  

Keywords:  Cladribine; Immunoglobulin; Lymphocytes; Multiple sclerosis

Mesh:

Substances:

Year:  2021        PMID: 34871857     DOI: 10.1016/j.msard.2021.103431

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


× No keyword cloud information.
  1 in total

1.  Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study.

Authors:  Nicola Capasso; Raffaele Palladino; Vincenza Cerbone; Antonio Luca Spiezia; Bianca Covelli; Antonia Fiore; Roberta Lanzillo; Antonio Carotenuto; Maria Petracca; Lucia Stanziola; Giulia Scalia; Vincenzo Brescia Morra; Marcello Moccia
Journal:  J Neurol       Date:  2022-09-01       Impact factor: 6.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.